Global and United States Saliva-based Screening Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Saliva-based Screening Market
This report focuses on global and United States Saliva-based Screening market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Saliva-based Screening market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Direct Sample to PCR accounting for % of the Saliva-based Screening global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Diagnostic Laboratories was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Saliva-based Screening market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Saliva-based Screening Scope and Market Size

Saliva-based Screening market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Saliva-based Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Saliva-based Screening market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Saliva-based Screening market is segmented into

Direct Sample to PCR

RT-qPCR

Lateral Flow Assays

Segment by Application, the Saliva-based Screening market is segmented into

Diagnostic Laboratories

Hospitals & Clinics

Others

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Saliva-based Screening Market Share Analysis

Saliva-based Screening market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Saliva-based Screening business, the date to enter into the Saliva-based Screening market, Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Thermo Fisher scientific

Qiagen

Hologic

Takara Bio Inc

Arcis Biotechnology Limited

GeneProof

Abacus ALS

Chai Inc.

Kolplast Group

Lucence Health INc

Vitagene

Therma Bright Inc

ACON Laboratories, Inc

TODA PHARMA

Norgen Biotek Corp.

Assure Tech. (Hangzhou) Co., Ltd

Beijing Hotgen Biotech Co., Ltd

Nantong Diagnos Biotechnology Co., Ltd

NeuMoDx Molecular, Inc.

KYODO INTERNATIONAL INC.

Canvax

Zymo Research Corporation.

Salimetrics

NEST Scientific USA

Miraclean Technology Co. Ltd

Mawi DNA Technologies

Cell Projects Ltd.